Stocks

J&J reaches $230 million opioid settlement with New York state By Reuters

© Reuters. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake

NEW YORK (Reuters) – Johnson & Johnson (NYSE:) agreed to pay about $230 million to resolve claims it helped fuel an opioid crisis in New York, the state’s attorney general said on Saturday.

The agreement addresses claims brought by Attorney General Letitia James, and will remove Johnson & Johnson as a defendant in a broader trial over opioids scheduled to begin next week.

J&J did not admit liability or wrongdoing in agreeing to settle. It said the agreement was consistent with its prior agreement to pay $5 billion to settle opioid claims by states, cities, counties and tribal governments nationwide.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button